NASDAQ:LAB Standard BioTools Q4 2025 Earnings Report $0.77 +0.04 (+5.45%) Closing price 09/18/2026 04:00 PM EasternExtended Trading$0.76 0.00 (-0.62%) As of 09/18/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Standard BioTools EPS ResultsActual EPS$0.05Consensus EPS -$0.03Beat/MissBeat by +$0.08One Year Ago EPSN/AStandard BioTools Revenue ResultsActual Revenue$23.80 millionExpected Revenue$18.50 millionBeat/MissBeat by +$5.30 millionYoY Revenue GrowthN/AStandard BioTools Announcement DetailsQuarterQ4 2025Date2/24/2026TimeAfter Market ClosesConference Call DateTuesday, February 24, 2026Conference Call Time4:00PM ETUpcoming EarningsStandard BioTools' Q3 2026 earnings is estimated for Tuesday, November 3, 2026, based on past reporting schedules, with a conference call scheduled on Thursday, November 5, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (8-K)Annual Report (10-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Annual report(10-K) Standard BioTools Earnings HeadlinesStandard BioTools Q2 Results Highlight Strategic RestructuringAugust 8, 2026 | theglobeandmail.comStandard BioTools Reports Second Quarter 2026 Financial ResultsAugust 5, 2026 | globenewswire.comA new kind of civil war is coming after election day?Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the political and investment landscape. Whitney Tilson believes tensions may come to a head at midnight on November 4th, the day after the midterm elections, with major implications for your portfolio. | Stansberry Research (Ad)Standard BioTools Announces Sale of Mass Cytometry Business and Illumina's Buyout of Contingent Payments to Advance Merger with Treeline BiosciencesJuly 28, 2026 | globenewswire.comStandard BioTools Inc.July 25, 2026 | marketwatch.comStandard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026July 22, 2026 | globenewswire.comSee More Standard BioTools Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Standard BioTools? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Standard BioTools and other key companies, straight to your email. Email Address About Standard BioToolsStandard BioTools (NASDAQ:LAB) (NASDAQ: LAB) develops and supplies technologies used to advance biomedical research, with a focus on single-cell analysis, spatial biology and proteomics. Its products are designed to help researchers characterize cells, tissues and biological samples at high resolution for applications including immunology, oncology, infectious disease research and drug development. The company’s portfolio includes mass cytometry systems and reagents sold under the CyTOF and Maxpar brands, as well as imaging technologies for analyzing the spatial distribution of proteins and other biomarkers in tissue samples. Standard BioTools also provides microfluidic and single-cell analysis platforms, consumables, software and related services. Through its combination with SomaLogic, the company also offers the SomaScan proteomics platform, which enables broad protein biomarker measurement from biological samples. Standard BioTools was formerly known as Fluidigm and adopted its current name following the completion of its combination with SomaLogic in 2023. The company serves academic institutions, pharmaceutical and biotechnology companies, clinical research organizations and other laboratories internationally. Standard BioTools is headquartered in South San Francisco, California, and is led by President and Chief Executive Officer Michael Egholm.View Standard BioTools ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles J.B. Hunt's Stock Plunges After Market Misprices Profit WarningLennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. HousingLennar's Q3 Miss Hides a Stronger Operating Story Beneath the Housing SlumpAeluma’s Selloff Could Be Setting Up Its Next Big MoveBraze Beat Expectations—Now 2 SaaS Peers Are in FocusPriced for a Pullback or More Gains? These 3 Stocks Are Testing the LimitsCoreWeave’s Vera Rubin Lead Comes Down to Speed, Power, and Scale Upcoming Earnings Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/8/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
